Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
TeraWulf
WULF
Canaan
CAN
US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.5150
- -0.0052-1.00%
Trading Dec 12 14:59 ET
3.50MMarket Cap-0.41P/E (TTM)
0.5488High0.5070Low29.38KVolume0.5320Open0.5202Pre Close15.16KTurnover0.51%Turnover RatioLossP/E (Static)6.79MShares1.870052wk High4.86P/B3.00MFloat Cap0.451552wk Low--Dividend TTM5.82MShs Float19.5600Historical High--Div YieldTTM8.04%Amplitude0.4515Historical Low0.5150Avg Price1Lot Size
Protagenic Therapeutics Key Stats
EPS
According to the latest financial report of Protagenic Therapeutics, the latest earnings per share (TTM) for the company is -0.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Protagenic Therapeutics's free cash flow? The latest report shows it as -185.66K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Protagenic Therapeutics shows that the company's current ratio is 1.80, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Protagenic Therapeutics, the quick ratio is 1.34, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Protagenic Therapeutics? The latest ROE figure is -84.79%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Protagenic Therapeutics, the total asset return on investment (ROA) is -43.07%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Protagenic Therapeutics's latest financial report to see how their gross margin is doing - currently at -5.50%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Protagenic Therapeutics, the net profit margin is -36.69%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.